Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shalender Bhasin, M.B.,B.S.

Co-Author

This page shows the publications co-authored by Shalender Bhasin and Tom Storer.
Connection Strength

8.385
  1. Maximizing Participant and Staff Safety During Assessment of Physical Function in the COVID-19 Era. J Am Geriatr Soc. 2021 01; 69(1):12-17.
    View in: PubMed
    Score: 0.945
  2. Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men. J Clin Endocrinol Metab. 2017 02 01; 102(2):583-593.
    View in: PubMed
    Score: 0.722
  3. Anabolic applications of androgens for functional limitations associated with aging and chronic illness. Front Horm Res. 2009; 37:163-182.
    View in: PubMed
    Score: 0.413
  4. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc. 2008 Nov; 56(11):1991-9.
    View in: PubMed
    Score: 0.404
  5. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment. J Clin Endocrinol Metab. 2005 Aug; 90(8):4474-82.
    View in: PubMed
    Score: 0.321
  6. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005 Feb; 90(2):678-88.
    View in: PubMed
    Score: 0.310
  7. Androgen effects on body composition. Growth Horm IGF Res. 2003 Aug; 13 Suppl A:S63-71.
    View in: PubMed
    Score: 0.283
  8. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003 Apr; 88(4):1478-85.
    View in: PubMed
    Score: 0.277
  9. Effect of Protein Intake on Visceral Abdominal Fat and Metabolic Biomarkers in Older Men With Functional Limitations: Results From a Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2021 05 22; 76(6):1084-1089.
    View in: PubMed
    Score: 0.243
  10. Clinically Important Differences for Mobility Measures Derived from the Testosterone Trials. J Am Geriatr Soc. 2021 02; 69(2):517-523.
    View in: PubMed
    Score: 0.235
  11. A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries. N Engl J Med. 2020 07 09; 383(2):129-140.
    View in: PubMed
    Score: 0.229
  12. The Stair Climb Power Test as an Efficacy Outcome in Randomized Trials of Function Promoting Therapies in Older Men. J Gerontol A Biol Sci Med Sci. 2020 05 22; 75(6):1167-1175.
    View in: PubMed
    Score: 0.227
  13. Circulating Biomarkers of Testosterone's Anabolic Effects on Fat-Free Mass. J Clin Endocrinol Metab. 2019 May 23.
    View in: PubMed
    Score: 0.212
  14. Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials. Lancet Diabetes Endocrinol. 2018 11; 6(11):879-890.
    View in: PubMed
    Score: 0.204
  15. Long-Term Testosterone Supplementation in Older Men Attenuates Age-Related Decline in Aerobic Capacity. J Clin Endocrinol Metab. 2018 08 01; 103(8):2861-2869.
    View in: PubMed
    Score: 0.200
  16. Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE): A Cluster-Randomized Pragmatic Trial of a Multifactorial Fall Injury Prevention Strategy: Design and Methods. J Gerontol A Biol Sci Med Sci. 2018 07 09; 73(8):1053-1061.
    View in: PubMed
    Score: 0.199
  17. Effect of Protein Intake on Lean Body Mass in Functionally Limited Older Men: A Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):530-541.
    View in: PubMed
    Score: 0.196
  18. Design of a randomized trial to determine the optimum protein intake to preserve lean body mass and to optimize response to a promyogenic anabolic agent in older men with physical functional limitation. Contemp Clin Trials. 2017 07; 58:86-93.
    View in: PubMed
    Score: 0.184
  19. Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss. J Clin Endocrinol Metab. 2016 12; 101(12):4669-4680.
    View in: PubMed
    Score: 0.176
  20. Testosterone Attenuates Age-Related Fall in Aerobic Function in Mobility Limited Older Men With Low Testosterone. J Clin Endocrinol Metab. 2016 Jun; 101(6):2562-9.
    View in: PubMed
    Score: 0.171
  21. Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial. JAMA. 2015 Aug 11; 314(6):570-81.
    View in: PubMed
    Score: 0.163
  22. Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause. 2014 Jun; 21(6):612-23.
    View in: PubMed
    Score: 0.150
  23. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci. 2013 Jan; 68(1):87-95.
    View in: PubMed
    Score: 0.129
  24. Effect of testosterone supplementation with and without a dual 5a-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA. 2012 Mar 07; 307(9):931-9.
    View in: PubMed
    Score: 0.129
  25. Novel strategies for improving physical function. Horm Res Paediatr. 2011; 76 Suppl 1:17-23.
    View in: PubMed
    Score: 0.123
  26. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci. 2011 Oct; 66(10):1090-9.
    View in: PubMed
    Score: 0.122
  27. Adverse events associated with testosterone administration. N Engl J Med. 2010 Jul 08; 363(2):109-22.
    View in: PubMed
    Score: 0.114
  28. Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods. Contemp Clin Trials. 2009 Mar; 30(2):133-40.
    View in: PubMed
    Score: 0.102
  29. Tests of muscle strength and physical function: reliability and discrimination of performance in younger and older men and older men with mobility limitations. J Am Geriatr Soc. 2008 Nov; 56(11):2118-23.
    View in: PubMed
    Score: 0.101
  30. Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss. Am J Physiol Endocrinol Metab. 2008 Jun; 294(6):E1135-43.
    View in: PubMed
    Score: 0.098
  31. Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab. 2006 Mar; 2(3):146-59.
    View in: PubMed
    Score: 0.085
  32. Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab. 2005 Jul; 90(7):3838-46.
    View in: PubMed
    Score: 0.080
  33. Delta-4-androstene-3,17-dione binds androgen receptor, promotes myogenesis in vitro, and increases serum testosterone levels, fat-free mass, and muscle strength in hypogonadal men. J Clin Endocrinol Metab. 2005 Feb; 90(2):855-63.
    View in: PubMed
    Score: 0.077
  34. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):870-8.
    View in: PubMed
    Score: 0.076
  35. Development of models to predict anabolic response to testosterone administration in healthy young men. Am J Physiol Endocrinol Metab. 2003 May; 284(5):E1009-17.
    View in: PubMed
    Score: 0.068
  36. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab. 2002 Jul; 283(1):E154-64.
    View in: PubMed
    Score: 0.066
  37. Effect of a Multifactorial Fall Injury Prevention Intervention on Patient Well-Being: The STRIDE Study. J Am Geriatr Soc. 2021 01; 69(1):173-179.
    View in: PubMed
    Score: 0.058
  38. The effects of testosterone administration on muscle areas of the trunk and pelvic floor in hysterectomized women with low testosterone levels: proof-of-concept study. Menopause. 2019 12; 26(12):1405-1414.
    View in: PubMed
    Score: 0.055
  39. Long-Term Testosterone Administration on Insulin Sensitivity in Older Men With Low or Low-Normal Testosterone Levels. J Clin Endocrinol Metab. 2018 04 01; 103(4):1678-1685.
    View in: PubMed
    Score: 0.049
  40. Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials. J Clin Endocrinol Metab. 2017 05 01; 102(5):1478-1485.
    View in: PubMed
    Score: 0.046
  41. Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial. Lancet Diabetes Endocrinol. 2016 08; 4(8):657-665.
    View in: PubMed
    Score: 0.043
  42. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016 Feb 18; 374(7):611-24.
    View in: PubMed
    Score: 0.042
  43. Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab. 2015 Mar; 100(3):1146-55.
    View in: PubMed
    Score: 0.039
  44. The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials. 2014 06; 11(3):362-375.
    View in: PubMed
    Score: 0.038
  45. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011 Jul; 12(6):403-9.
    View in: PubMed
    Score: 0.031
  46. Identification of serum biomarkers for aging and anabolic response. Immun Ageing. 2011 Jun 20; 8(1):5.
    View in: PubMed
    Score: 0.031
  47. Habitual physical activity levels are associated with performance in measures of physical function and mobility in older men. J Am Geriatr Soc. 2010 Sep; 58(9):1727-33.
    View in: PubMed
    Score: 0.029
  48. Position stand on androgen and human growth hormone use. J Strength Cond Res. 2009 Aug; 23(5 Suppl):S1-S59.
    View in: PubMed
    Score: 0.027
  49. Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol (1985). 2007 Oct; 103(4):1299-310.
    View in: PubMed
    Score: 0.023
  50. Hormonal regulators of muscle and metabolism in aging (HORMA): design and conduct of a complex, double masked multicenter trial. Clin Trials. 2007; 4(5):560-71.
    View in: PubMed
    Score: 0.022
  51. Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. Am J Physiol Endocrinol Metab. 2003 Jan; 284(1):E120-8.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.